Even if it's not a huge purchase, we think it was good to see that Per Lindblad, the Board Member of Nyfosa AB (publ) (STO:NYF) recently shelled out kr161k to buy stock, at kr80.43 per share. Even though that isn't a massive buy, it did increase their holding by 67%, which is a arguably a good sign.
The Last 12 Months Of Insider Transactions At Nyfosa
Over the last year, we can see that the biggest insider purchase was by Chief Operating Officer Stina Hök for kr494k worth of shares, at about kr61.70 per share. We do like to see buying, but this purchase was made at well below the current price of kr80.20. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.
In the last twelve months Nyfosa insiders were buying shares, but not selling. The chart below shows insider transactions (by individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
Nyfosa is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.
Insider Ownership of Nyfosa
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Nyfosa insiders own about kr568m worth of shares. That equates to 4.2% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
So What Do The Nyfosa Insider Transactions Indicate?
The recent insider purchase is heartening. And an analysis of the transactions over the last year also gives us confidence. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Nyfosa. Looks promising! Therefore, you should should definitely take a look at this FREE report showing analyst forecasts for Nyfosa.
But note: Nyfosa may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
If you spot an error that warrants correction, please contact the editor at email@example.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.